• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Invivo Therapeutics resumes second primate study

Invivo Therapeutics resumes second primate study

October 20, 2009 By MassDevice staff

InVivo Therapeutics Inc. is back on track with a second primate study, just a month after filing a lawsuit against its former contract research facility.

CEO Frank Reynolds told MassDevice in an email that the Cambridge, Mass.-based spinal tissue regeneration developer’s second primate study is already eight weeks in, having begun on August 20. Reynolds said the company went back to St. Kitts Biomedical Research Facility in St. Kitts, U.S. Virgin Islands, the site of its initial primate study back in 2007.

“We are thrilled with the study so far,” Reynolds wrote.

Back in September, InVivo, an early-stage medical device company that’s working on treatments for severe spinal cord injuries using implantable polymers, filed suit against Oregon Health & Science University, alleging that the CRO’s negligence caused a flubbed primate study of the treatment.

Several monkeys had to be euthanized during the trial, according to court filings, because of bladder infections they developed after undergoing surgical procedures to sever their spinal cords and have InVivo’s device implanted.

InVivo claimed that the setback cost the company more than $500,000 and significantly derailed its plans, to the point that the firm may be in serious jeopardy, according to court documents.

OHSU vigorously denied the allegations.

“We take issue with everything,” said spokesman Jim Newman, who sent us a list refuting each of InVivo’s accusations one by one. The lab denied allegations that it failed to provide enough monkeys for the study and put the blame for halting the surgeries on InVivo surgeons.

Alexander Furey, an attorney for InVivo, said the case is still moving forward and they are awaiting a response from OHSU.

For his part, Reynolds wrote that the primate study is using the “same exact study protocol” used during the OHSU study and that “everything is fantastic.”

Filed Under: Business/Financial News, Neurological, Spine

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy